- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.10.25 | Sona Nanotech Inc: Sona Nanotech sees 80% response in cancer study | 1 | Stockwatch | ||
| 20.10.25 | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 552 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| 18.10.25 | Sona Nanotech Inc: Sona Nanotech to host investor webinar Oct. 20 | 1 | Stockwatch | ||
| 17.10.25 | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 1.003 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen | |
| 26.08.25 | Sona Nanotech Inc: Sona completes treatment of first patient cohort in FS | 3 | Stockwatch | ||
| 25.08.25 | Sona Nanotech advances cancer therapy with promising early results | 1 | The Market Herald Canada | ||
| 25.08.25 | Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial | 844 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 23.07.25 | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 723 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 07.07.25 | Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy | 923 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 27.06.25 | Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial | 697 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 16.06.25 | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 607 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen | |
| 27.05.25 | Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study | 908 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety... ► Artikel lesen | |
| 15.05.25 | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 1.178 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen | |
| 07.05.25 | Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration | 898 | Newsfile | Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)... ► Artikel lesen | |
| 07.05.25 | BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration | 988 | PR Newswire | VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc.... ► Artikel lesen | |
| 01.05.25 | Sona Nanotech Inc.: Sona Nanotech Announces Annual Options Grants | 1.360 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under... ► Artikel lesen | |
| 19.03.25 | Sona Nanotech Inc.: Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model | 1.306 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted... ► Artikel lesen | |
| 06.03.25 | Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 | 739 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.About... ► Artikel lesen | |
| 12.02.25 | Sona Nanotech Inc.: Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference | 680 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - February 12, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,000 | +0,88 % | EQS-DD: Formycon AG: Active Ownership Fund SICAV SIF SCS, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
14.01.2026 / 19:31... ► Artikel lesen | |
| OBDUCAT | 0,003 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| ONTO INNOVATION | 176,00 | -0,56 % | Beyond The Numbers: 8 Analysts Discuss Onto Innovation Stock | ||
| SOLESENCE | 1,370 | +3,01 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| VEECO INSTRUMENTS | 25,000 | -3,85 % | Axcelis Technologies, Inc.: Axcelis Stockholders Approve Merger with Veeco | BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all... ► Artikel lesen | |
| KOPIN | 2,056 | +1,08 % | Kopin-Aktie legt zu: Rüstungsauftrag für Pilotenhelm-Displays erhalten | ||
| RIBER | 4,980 | -0,80 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| GAUZY | 0,884 | +0,15 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| GOMSPACE | 2,000 | +1,21 % | GomSpace Group AB: GomSpace announces 2026 market guidance with strong profitable growth | GomSpace, a leading provider of small satellite solutions, today provides an update on its 2026 financial guidance.
The company is pleased to announce comprehensive market guidance for 2026, reflecting... ► Artikel lesen | |
| ZENTEK | 0,540 | -5,26 % | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | |
| LAMPETIA | 0,080 | +9,59 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOFORM FINLAND | 0,835 | 0,00 % | Nanoform Finland Oyj: Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030 | Nanoform Finland Plc | Inside Information | January 07, 2026 at 08:05:00 EET
Helsinki, Finland - Nanoform Finland Plc ("Nanoform") starts change negotiations in accordance with the Act on Cooperation.... ► Artikel lesen | |
| QUANTUM BASE | 0,284 | +9,23 % | Quantum Base Hldgs - Director Dealings | ||
| ACACIA RESEARCH | 3,300 | -1,79 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 54,50 | +1,87 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen |
Das Unternehmen SONA NANOTECH INC kann der Branche Nanotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.